Press release
Giant-Cell Arteritis Market Landscape to 2034: Key Forces Shaping the Next Decade of Growth
Giant-Cell Arteritis
How Large Will the Giant-Cell Arteritis Market Size By 2025?
The market size for giant-cell arteritis has seen robust growth in the past few years. It is projected to increase from $1.07 billion in 2024 to $1.12 billion in 2025, representing a compound annual growth rate (CAGR) of 5.3%. Factors contributing to this growth during the historical period include advancements in epidemiological research, genetic knowledge, considerable use of biologics, enhanced diagnostic methods, and the advent of targeted therapies and biologics.
How Big Is the Giant-Cell Arteritis Market Size Expected to Grow by 2029?
Expectations are high for substantial expansion in the giant-cell arteritis market over the coming years. The market size is anticipated to reach $1.36 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 5.0%. The surge projected in this period is underpinned by factors such as increased diagnostic rates, an aging demographic, escalating healthcare spending, patient activism, and geographic expansion. Prominent trends anticipated within this forecast range encompass the advancements in biomarker identification and validation, the creation of therapies aimed at specific molecular pathways, the uptake of cutting-edge imaging systems, breakthroughs in drug delivery, and the employment of AI algorithms for predictive analytics.
View the full report here:
https://www.thebusinessresearchcompany.com/report/giant-cell-arteritis-global-market-report
Which Key Market Drivers Powering Giant-Cell Arteritis Market Expansion and Growth?
The rising focus on personalized healthcare is predicted to drive expansion in the giant-cell arteritis market. Personalized healthcare uses each patient's unique genetic, environmental, and lifestyle factors to shape treatment plans. It has become increasingly common, thanks to advancements in genomics, biotechnology, and data analytics, that allow for the development of targeted therapies that enhance treatment effectiveness and diminish negative outcomes. In the context of giant-cell arteritis (GCA), personalized care can guide treatment choices based on each patient's unique genetic susceptibility, immune profiles, and disease symptoms. The Personalized Medicine Coalition (PMC), a non-profit organization based in the U.S., stated in February 2024 that more than a third of new medicines authorized by the U.S. Food and Drug Administration (FDA) for the fourth consecutive year in 2023 were personalized medicines. The FDA approved 16 new personalized treatments for rare diseases in 2023, a sharp increase from six in 2022. Apart from these, the approvals in 2023 also covered seven cancer drugs and three treatments for other various illnesses. Therefore, the surge in focus on personalized healthcare is believed to be a key driver in the growth of the giant-cell arteritis market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17162&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Giant-Cell Arteritis Market?
Leading companies in the giant-cell arteritis market are focusing on the creation of new solutions like biosimilar to widen patient treatment choices and cater to unfulfilled healthcare requirements. A biosimilar is a biopharmaceutical product that closely aligns with an already sanctioned biological product without any significant contrasts in safety, purity, and effectiveness. For instance, Tocilizumab-aazg, a biosimilar launched by Fresenius SE & Co. KGaA, a German healthcare company, in the US in April 2024, is intended for the treatment of chronic autoimmune diseases. This therapeutic drug is endorsed for ailments such as rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, and giant-cell arteritis. The approval of this biosimilar was rooted in data acquired from a randomized, double-blind, single-dose, parallel phase 1 trial, which compared its pharmacokinetics, safety, and immunogenicity to tocilizumab reference products from both the US and EU in three separate patient cohorts.
What Are the Emerging Segments in the Giant-Cell Arteritis Market?
The giant-cell arteritis market covered in this report is segmented -
1) By Therapeutics: Prednisone, Methotrexate, Tocilizumab, Aspirin
2) By Mechanism Of Action: Corticosteroids, Immunosuppressive Agents, Anticoagulants, Other Mechanisms Of Action
3) By Route Of Administration: Oral, Intravenous, Subcutaneous, Other Routes Of Administration
Subsegments:
1) By Prednisone: Oral Prednisone, Intravenous (IV) Prednisone, Low-Dose Prednisone Therapy, High-Dose Prednisone Therapy
2) By Methotrexate: Oral Methotrexate, Subcutaneous Methotrexate, Methotrexate Monotherapy, Methotrexate Combination Therapy
3) By Tocilizumab: Intravenous Tocilizumab, Subcutaneous Tocilizumab, Tocilizumab Monotherapy, Tocilizumab In Combination With Corticosteroids
4) By Aspirin: Low-Dose Aspirin Therapy, Aspirin For Cardiovascular Risk Management, Aspirin In Combination Therapy, Enteric-Coated Aspirin
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=17162&type=smp
Who Are the Global Leaders in the Giant-Cell Arteritis Market?
Major companies operating in the giant-cell arteritis market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., CSL Limited, Kiniksa Pharmaceuticals Ltd., MorphoSys AG
Which are the Top Profitable Regional Markets for the Giant-Cell Arteritis Industry?
North America was the largest region in the giant-cell arteritis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the giant-cell arteritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17162
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Giant-Cell Arteritis Market Landscape to 2034: Key Forces Shaping the Next Decade of Growth here
News-ID: 4135164 • Views: …
More Releases from The Business Research Company
Percutaneous Puncture Surgery Robot Market Analysis Highlights Growth To $3.54 B …
The market for percutaneous puncture surgery robots is on the verge of significant expansion, driven by rapid technological advances and increasing adoption in healthcare settings. As robotic systems become more sophisticated and integrated with cutting-edge technologies, this sector is set to transform minimally invasive surgical procedures. Below is a detailed exploration of the market's size, key players, trends, and segmentation that shape its future trajectory.
Projected Growth and Market Size of…
Pedicle Screw Systems Market Study Highlights How Industry Demand Is Evolving
The pedicle screw systems market is set to experience significant expansion in the coming years, driven by advancements in spinal surgery techniques and increasing patient demand. This market's evolution reflects growing medical needs and ongoing innovation, positioning it for substantial growth by 2030.
Forecasted Market Size and Growth Trajectory for Pedicle Screw Systems
The value of the pedicle screw systems market is projected to reach $7.65 billion by 2030, growing…
Pediatric Orthopedic Implants Market Research Reveals Strong 10.8% CAGR Outlook …
The pediatric orthopedic implants market is on track for significant expansion as advancements in technology and growing healthcare needs drive demand. Innovations in implant design and personalized treatment options are setting the stage for transformative growth in this specialized segment of medical devices. Below is a detailed overview of the current market size, key industry players, emerging trends, and segmentation that define this market's future.
Pediatric Orthopedic Implants Market Size and…
Pediatric Interventional Cardiology Market Intelligence Report Covers Trends, Se …
The pediatric interventional cardiology field is on track for significant expansion, driven by advances in medical technology and growing demand for specialized cardiac care for children. This sector is expected to see dynamic growth as innovative devices and techniques become more widely adopted to improve patient outcomes.
Projected Market Size and Growth Trajectory of the Pediatric Interventional Cardiology Market
The market for pediatric interventional cardiology is forecasted to grow steadily,…
More Releases for Arteritis
Giant Cell Arteritis Market: Growth Momentum Across 7MM to 2034 - DelveInsight
The Giant Cell Arteritis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Giant Cell Arteritis pipeline products will significantly revolutionize the Giant Cell Arteritis market dynamics.
DelveInsight's "Giant Cell Arteritis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Giant Cell Arteritis, historical and forecasted epidemiology as well as the Giant Cell Arteritis market…
Giant Cell Arteritis Treatment Market: Global Trends, Growth, and Forecast 2025- …
The giant cell arteritis treatment market is witnessing significant traction with the increasing awareness of autoimmune disorders and the rising healthcare expenditure globally. The market, which was valued at USD 147.50 million in 2024, is projected to expand at a CAGR of 5.20% during the forecast period of 2025 to 2034, reaching a value of USD 244.88 million by 2034. With the growing geriatric population-particularly those above 50 years old-who…
Giant Cell Arteritis Treatment Market Size, Share, Industry Growth 2032
Giant Cell Arteritis Treatment Market Overview
Giant Cell Arteritis (GCA) is a systemic vasculitis condition that causes inflammation of the blood vessels, primarily affecting the large arteries in the head, such as the temporal arteries. The global Giant Cell Arteritis Treatment Market is driven by rising healthcare expenditure and increased awareness of autoimmune diseases. Treatments focus on reducing inflammation, controlling symptoms, and preventing complications, primarily using corticosteroids and other immunosuppressive therapies.…
Giant-Cell Arteritis Market Size, Share Analysis And Growth Trends 2033
The new report published by The Business Research Company, titled Giant-Cell Arteritis Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the giant-cell arteritis market size has grown steadily in recent years. It will grow from $1.02 billion in 2023…
Giant Cell Arteritis Therapeutics Market Forecast 2024-2030: Advances in Treatme …
Breakthrough Treatment for Giant Cell Arteritis Sparks Surge in Global Market Valuation
Giant Cell Arteritis, a prevalent form of systemic vasculitis affecting individuals over 50, is witnessing a paradigm shift in its treatment landscape. The condition, characterized by granulomatous medium and large-vessel inflammation, is most common among Caucasians, particularly those in Scandinavian countries and of northern European descent. However, the European market is anticipated to experience accelerated growth, challenging previous demographic…
Global Giant Cell Arteritis Treatment Market Forecast 2023-2028 Under Inflation
This Giant Cell Arteritis Treatment market report assists major companies in generating revenues by making the appropriate investments and taking the necessary actions to alter perceptions. It addresses compliance hurdles as well as future possibilities as a whole. By adhering to these business indicators, industries may create goals for their businesses, overcome the competition, follow strategic goals, and, as a result, make large profits. It allows businesses to take a…
